|
⚲
|
| Keyboard |
| McCourt Marion
✚
|
|
|---|---|
| CIK # | 0001663758 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001663758] | |
| 4 | [0001663758] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McCourt Marion | |
| Regeneron Pharmaceuticals Inc | |
| Scynexis Inc | |
| CytomX Therapeutics Inc | |
| Sio Gene Therapies Inc | |
| Medivation Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-12-09 | Tax withheld | 1,021 | $701.51 | 716,242 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-12-08 | Tax withheld | 1,336 | $712.94 | 952,488 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-12-05 | Grant | 2,476 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2025-12-05 | Grant | 12,210 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-12-16 | Tax withheld | 759 | $730.81 | 554,685 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-12-09 | Tax withheld | 274 | $787.00 | 215,638 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-12-06 | Grant | 2,332 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-12-06 | Grant | 8,981 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-11-01 | Sell | 1,000 | $844.61 | 844,610 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-11-01 | Option exercise | 1,000 | $381.40 | 381,400 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-11-01 | Option exercise | 1,000 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-10-01 | Sell | 1,000 | $1,054.06 | 1,054,060 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-10-01 | Option exercise | 1,000 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-10-01 | Option exercise | 1,000 | $381.40 | 381,400 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-09-03 | Option exercise | 1,000 | $381.40 | 381,400 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-09-03 | Sell | 1,000 | $1,178.73 | 1,178,730 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-09-03 | Option exercise | 1,000 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-08-01 | Sell | 1,137 | $1,060.86 | 1,206,198 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-08-01 | Option exercise | 1,137 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-08-01 | Option exercise | 1,137 | $372.46 | 423,487 |
| showing 20 of 170 most recent transactions | |||||